131 related articles for article (PubMed ID: 19887856)
1. Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?
de Jong EP; Lopriore E; Vossen AC; Steggerda SJ; Te Pas AB; Kroes AC; Walther FJ
Neonatology; 2010; 97(3):274-8. PubMed ID: 19887856
[TBL] [Abstract][Full Text] [Related]
2. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?
van der Weiden S; de Jong EP; Te Pas AB; Middeldorp JM; Vossen AC; Rijken M; Walther FJ; Lopriore E
Early Hum Dev; 2011 Feb; 87(2):103-7. PubMed ID: 21145674
[TBL] [Abstract][Full Text] [Related]
3. [Cytomegalovirus infection--diagnostic and therapeutic difficulties in neonatal intensive care unit].
Tomasik T; Opozda A; Pietrzyk JJ
Przegl Lek; 2010; 67(1):18-24. PubMed ID: 20509566
[TBL] [Abstract][Full Text] [Related]
4. Routine TORCH screening is not warranted in neonates with subependymal cysts.
van der Weiden S; Steggerda SJ; Te Pas AB; Vossen AC; Walther FJ; Lopriore E
Early Hum Dev; 2010 Apr; 86(4):203-7. PubMed ID: 20227842
[TBL] [Abstract][Full Text] [Related]
5. Yield and costs of screening growth-retarded infants for torch infections.
Khan NA; Kazzi SN
Am J Perinatol; 2000; 17(3):131-5. PubMed ID: 11012137
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of serological findings and clinical manifestations of TORCH infections in newborns].
Wang L; Li KH; Liu H; Liu JY; Li YJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):283-4. PubMed ID: 15340579
[TBL] [Abstract][Full Text] [Related]
7. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection?
Amir J; Schwarz M; Levy I; Haimi-Cohen Y; Pardo J
Arch Dis Child; 2011 Sep; 96(9):846-50. PubMed ID: 21715394
[TBL] [Abstract][Full Text] [Related]
8. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
[TBL] [Abstract][Full Text] [Related]
9. TORCH serologies and specific IgM antibody determination in acquired and congenital infections.
Fung JC; Tilton RC
Ann Clin Lab Sci; 1985; 15(3):204-11. PubMed ID: 2986514
[TBL] [Abstract][Full Text] [Related]
10. The etiology of lenticulostriate vasculopathy and the role of congenital infections.
Cantey JB; Sisman J
Early Hum Dev; 2015 Jul; 91(7):427-30. PubMed ID: 25960415
[TBL] [Abstract][Full Text] [Related]
11. The C in TORCH: a cost-effective alternative to screening small-for-gestational-age infants.
Wei D; Sardesai SR; Barton L
Neonatology; 2014; 106(1):24-9. PubMed ID: 24732345
[TBL] [Abstract][Full Text] [Related]
12. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection?
Yamamoto AY; Mussi-Pinhata MM; Marin LJ; Brito RM; Oliveira PF; Coelho TB
J Clin Virol; 2006 Jul; 36(3):228-30. PubMed ID: 16750653
[TBL] [Abstract][Full Text] [Related]
13. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study.
Abu Shqara R; Or S; Abu Zraki A; Rizik J; Glikman D; Rechnitzer H; Lowenstein L; Frank Wolf M
Pediatr Infect Dis J; 2024 Jan; 43(1):69-73. PubMed ID: 37725823
[TBL] [Abstract][Full Text] [Related]
15. [TORCH infections in mothers as a cause of neonatal morbidity].
Mladina N; Mehikić G; Pasić A
Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
[TBL] [Abstract][Full Text] [Related]
16. Umbilical cord blood screening for cytomegalovirus DNA by quantitative PCR.
Theiler RN; Caliendo AM; Pargman S; Raynor BD; Berga S; McPheeters M; Jamieson DJ
J Clin Virol; 2006 Dec; 37(4):313-6. PubMed ID: 17035082
[TBL] [Abstract][Full Text] [Related]
17. The use of TORCH titers.
Leland D; French ML; Kleiman MB; Schreiner RL
Pediatrics; 1983 Jul; 72(1):41-3. PubMed ID: 6306545
[TBL] [Abstract][Full Text] [Related]
18. Lenticulostriate echogenic vessels: clinical and sonographic study of 70 neonatal cases.
El Ayoubi M; de Bethmann O; Monset-Couchard M
Pediatr Radiol; 2003 Oct; 33(10):697-703. PubMed ID: 12904918
[TBL] [Abstract][Full Text] [Related]
19. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings.
Nijman J; de Vries LS; Koopman-Esseboom C; Uiterwaal CS; van Loon AM; Verboon-Maciolek MA
Arch Dis Child Fetal Neonatal Ed; 2012 Jul; 97(4):F259-63. PubMed ID: 22247412
[TBL] [Abstract][Full Text] [Related]
20. Association between lenticulostriate vasculopathy (LSV) and neonatal intraventricular hemorrhage (IVH).
Mittendorf R; Covert R; Pryde PG; Lee KS; Ben-Ami T; Yousefzadeh D
J Perinatol; 2004 Nov; 24(11):700-5. PubMed ID: 15254561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]